Search

Your search keyword '"Stefano Milani"' showing total 52 results
Start Over Author "Stefano Milani" Journal digestive and liver disease
52 results on '"Stefano Milani"'

1. AF.59 PREGNANCY AND INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE ANALYSIS OF A LARGE COHORT FROM A TERTIARY REFERRAL CENTRE

Author

Jenny Roselli, Tommaso Innocenti, S. Bagnoli, A. Taylor, Francesca Rogai, G. Macrì, E.N. Lynch, M. Gottin, Monica Milla, Claudia Campani, Stefano Milani, Gabriele Dragoni, and Andrea Galli

Subjects
medicine.medical_specialty, Pregnancy, Hepatology, business.industry, Tertiary referral centre, Internal medicine, Gastroenterology, Retrospective analysis, Medicine, business, medicine.disease, Inflammatory bowel disease, Large cohort
Published
2021
Full Text
View/download PDF

3. AF.45 IBUS-SAS FOR CROHN’S DISEASE ULTRASOUND ACTIVITY: INITIAL VALIDATION AND RESEARCH OF THE OPTIMAL CUT-OFF SCORE

Author

Francesca Rogai, L. Parisio, Jenny Roselli, S. Bagnoli, Andrea Galli, E.N. Lynch, C. Fiorini, Gabriele Dragoni, Tommaso Innocenti, Stefano Milani, Monica Milla, and G. Macrì

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Ultrasound, Gastroenterology, Medicine, Radiology, business, medicine.disease
Published
2021
Full Text
View/download PDF

4. OC.10.8 DISHEVELLED-ASSOCIATED ANTAGONIST OF B-CATENIN 2 (DACT2) IN PANCREATIC DUCTAL ADENOCARCINOMA

Author

Tommaso Mello, L. Picariello, I. Simeone, Elisabetta Ceni, Cecilia Grappone, Andrea Galli, Stefano Milani, Simone Polvani, A. Guida, Gabriele Dragoni, and Mirko Tarocchi

Subjects
chemistry.chemical_classification, Pancreatic ductal adenocarcinoma, Hepatology, chemistry, business.industry, Catenin, Gastroenterology, Antagonist, Cancer research, Medicine, business, Dishevelled
Published
2021
Full Text
View/download PDF

5. Metabolomic analysis with 1 H-NMR for non-invasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C

Author

Patrizia Bernini, Cecilia Grappone, Maria Rosa Biagini, Vito Annese, Stefano Milani, Maria Marsico, E. Lorefice, and T Gabbani

Subjects
0301 basic medicine, medicine.medical_specialty, Chronic hepatitis C, Hepatic fibrosis, Metabolomics, Proton nuclear magnetic resonance, Spectroscopy, Hepatitis C, Chronic, Humans, Liver Cirrhosis, Sensitivity and Specificity, Metabolome, Proton Magnetic Resonance Spectroscopy, Cirrhosis, Hepatology, business.industry, Gastroenterology, Urine, medicine.disease, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Chronic hepatitis, Fibrosis, 030220 oncology & carcinogenesis, Internal medicine, medicine, Proton NMR, business, Two-dimensional nuclear magnetic resonance spectroscopy
Abstract

Background The assessment of fibrosis degree in liver diseases is based on several non-invasive techniques, but none has been accurate. Aim This study employed proton nuclear magnetic resonance spectroscopy to identify metabolic profiles in serum and urine, specific for different fibrosis degree in chronic hepatitis C patients. Method 71 plasma, 73 serum, and 578 urine samples were collected. All samples were analyzed using 1H-NMR spectroscopy technique and three different NMR spectra were acquired for each serum/plasma sample. The data analyses were performed by partial least square regression, principal component analysis, and Monte Carlo cross-validation in a supervised methodology. Results The cross-validation test correctly assigned each sample to its specific donor with 98.44% accuracy for urine samples and 65% for serum/plasma samples. Advanced fibrosis and cirrhosis were recognized with 71% sensitivity for CPMG plasma spectra and 69% specificity for NOESY serum spectra. Accuracy for NOESY serum spectra was 68%. Noesy spectra recognized advanced fibrosis and cirrhosis with 71% sensitivity, 30% specificity, and 50% accuracy in urine samples. Conclusion Metabolomic analysis of urine spectra using 1H-NMR spectroscopy can recognize a specific individual profile in all patients with chronic hepatitis C. However, this method cannot yet differentiate with sufficient accuracy, patients with advanced fibrosis from patients with milder disease.

Published
2017
Full Text
View/download PDF

6. Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry

Author

Luisa Leoncini, Maria Rosa Biagini, Umberto Arena, Cristina Stasi, Stefano Milani, Giacomo Laffi, Fabio Marra, and S. Madiai

Subjects
Male, medicine.medical_specialty, Pathology, Biopsy, Gastroenterology, Cohort Studies, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Primary biliary cirrhosis, Fibrosis, Internal medicine, Image Processing, Computer-Assisted, medicine, Humans, Aspartate Aminotransferases, Stage (cooking), Sirius Red, Aged, Retrospective Studies, Hepatology, medicine.diagnostic_test, biology, Liver Cirrhosis, Biliary, business.industry, Biopsy, Needle, Alanine Transaminase, Retrospective cohort study, gamma-Glutamyltransferase, Middle Aged, Alkaline Phosphatase, medicine.disease, Liver, chemistry, Alanine transaminase, 030220 oncology & carcinogenesis, Disease Progression, biology.protein, Female, 030211 gastroenterology & hepatology, business, Biomarkers
Abstract

The accuracy of non-invasive methods for the quantification of liver fibrosis in primary biliary cholangitis (PBC) is still debated.To determine the histo-morphometric measurement of fibrotic tissue and to explore the possible association between indirect markers (APRI, FORNS, FIB-4, and Lok) and morphometry.Retrospective analysis of medical data from patients with PBC, on whom needle liver biopsy was performed as part of the diagnostic assessment. One section of each biopsy stained with Sirius red was used for calculating the percentage of collagen. Quantitative measure of fibrotic tissue (fibrosis morphometry) was calculated as a percentage of collagen content by digital image analysis. Morphometry results were divided into four groups reflecting Ludwig's staging and compared with values for indirect serum markers.50 PBC patients were enrolled (86% females, mean age 57 ± 12.30 years), 19 were Ludwig's stage I (38%), 14 stage II (28%), 12 stage III (24%), and five stage IV (10%). Morphometry results were significantly different among Ludwig stages (p0.05). No significant differences were found for indirect serum markers. A significant correlation was found between morphometry results and indirect serum markers tested (p0.05).In our cohort, the histo-morphometric values of fibrotic tissue increased progressively with Ludwig's stages of PBC, while non-invasive markers did not.

Published
2016
Full Text
View/download PDF

8. T04.01.7 MAINTENANCE OF CLINICAL REMISSION WITH SB5 BIOSIMILAR AFTER SWITCH FROM ADALIMUMAB ORIGINATOR: REAL-LIFE EXPERIENCE OF A TERTIARY REFERRAL CENTER

Author

Francesca Rogai, Saverio Caini, A. Pieraccini, S. Bagnoli, Gabriele Dragoni, Andrea Galli, Monica Milla, G. Macrì, and Stefano Milani

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, Adalimumab, Referral center, Biosimilar, Intensive care medicine, business, medicine.drug
Published
2020
Full Text
View/download PDF

10. Nuclear orphan receptor COUP-TF2 induces anoikis resistance, amoeboid migration and metastatic potential in hepatocellular carcinoma (HCC)

Author

Andrea Galli, Simone Polvani, Mireille Vasseur-Cognet, Mirko Tarocchi, Tommaso Mello, Stefano Milani, and Elisabetta Ceni

Subjects
Orphan receptor, Nuclear orphan receptor, COUP-TF2, anoikis resistance, amoeboid migration, metastatic potential, hepatocellular carcinoma (HCC), Hepatology, business.industry, Hepatocellular carcinoma, Anoikis resistance, Gastroenterology, Cancer research, Medicine, business, medicine.disease
Published
2019
Full Text
View/download PDF

11. Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C

Author

Massimo Pinzani, Cristina Stasi, Luisa Leoncini, Umberto Arena, Giacomo Laffi, Sara Renzo, Monica Monti, Fabio Marra, E. Triboli, Elena Pellegrini, Giampaolo Corti, Anna Linda Zignego, and Stefano Milani

Subjects
Adult, Liver Cirrhosis, Male, medicine.medical_specialty, Pathology, Genotype, Hepatitis C virus, medicine.disease_cause, Antiviral Agents, Gastroenterology, Polyethylene Glycols, Interquartile range, Pegylated interferon, Internal medicine, Ribavirin, Biopsy, medicine, Humans, Longitudinal Studies, Hepatology, medicine.diagnostic_test, business.industry, Interleukins, Interferon-alpha, Hepatitis C, Hepatitis C, Chronic, Middle Aged, Viral Load, medicine.disease, Elasticity, Recombinant Proteins, Liver, Relative risk, Liver biopsy, Elasticity Imaging Techniques, RNA, Viral, Drug Therapy, Combination, Female, Interferons, Transient elastography, business, medicine.drug
Abstract

Background Liver stiffness has been suggested as a parameter of fibrosis progression/regression in hepatitis C virus (HCV) patients. Aim To evaluate stiffness before and after peginterferon–ribavirin treatment. Methods Stiffness was prospectively measured in 74 HCV patients, 32 genotypes 1/4 (43.25%) and 42 genotypes 2/3 (56.75%), before, at end of treatment, and after 3 years of follow-up (49 patients). On the same study day, 21 patients underwent liver biopsy. Results In 55 patients with sustained virological response (74.32%), liver stiffness decreased significantly at end of therapy (6.8 ± 4.9 kPa) vs. baseline (9.5 ± 6.9 kPa, p = 0.04). The decrease vs. baseline was maintained in 30 sustained virological response patients after 3 years follow-up (6.8 ± 4.6 kPa vs. 10.8 ± 8.5 kPa, p = 0.0141). No difference was found at end of treatment vs. baseline (10.1 ± 4.7 kPa vs. 9.7 ± 4.2 kPa, p = 0.825) and after 3 years of follow-up vs. baseline (10.2 ± 3.4 kPa vs. 9.7 ± 4.2 kPa, p = 0.765) in null responders. Similar results were found in relapsers at end of treatment vs. baseline (13.7 ± 7.7 kPa vs. 15.2 ± 8.2 kPa, p = 0.74), and after 3 years of follow-up vs. baseline (16.9 ± 10.0 kPa vs. 15.2 ± 8.2 kPa, p = 0.734). Pre-treatment stiffness >12 kPa was significantly associated with no SVR ( p Conclusion Liver stiffness may be useful to assess long-term antiviral treatment response.

Published
2013
Full Text
View/download PDF

12. Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression

Author

Stefano Milani, M. Materozzi, Mirko Tarocchi, S. Tempesti, F. Zanieri, Tommaso Mello, Oxana Bereshchenko, Andrea Galli, Claus Nerlov, G. Marroncini, Simone Polvani, and Elisabetta Ceni

Subjects
0301 basic medicine, 030103 biophysics, Hepatology, business.industry, RPTOR, Gastroenterology, Carbohydrate metabolism, medicine.disease, 03 medical and health sciences, Hepatocellular carcinoma, Cancer research, Medicine, business, Protein kinase B, PI3K/AKT/mTOR pathway
Published
2016
Full Text
View/download PDF

13. The AAA+ ATPase Ruvbl1 coordinates liver metabolism and hepatocellular carcinoma progression

Author

Andrea Galli, F. Zanieri, S. Tempesti, M. Materozzi, Mirko Tarocchi, Elisabetta Ceni, I. Simeone, Claus Nerlov, Oxana Bereshchenko, Tommaso Mello, Simone Polvani, Stefano Milani, and G. Marroncini

Subjects
Liver metabolism, Hepatology, business.industry, Hepatocellular carcinoma, Gastroenterology, Cancer research, Medicine, business, medicine.disease, AAA proteins
Published
2015
Full Text
View/download PDF

14. PC.02.2 TARGET THERAPY: A TELOMERASE ACTIVATED THYMIDINE ANALOGUE PRO-DRUG FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

Author

G. Marroncini, Simone Polvani, F. Buccoliero, Tommaso Mello, A. Peired, Elisabetta Ceni, Stefano Milani, Mirko Tarocchi, and Andrea Galli

Subjects
Oncology, medicine.medical_specialty, Telomerase, Hepatology, business.industry, Thymidine analogue, Gastroenterology, Prodrug, medicine.disease, Internal medicine, Hepatocellular carcinoma, medicine, Cancer research, Target therapy, business
Published
2013
Full Text
View/download PDF

15. P.10.21 COUP-TFII DOWNREGULATION INHIBITS PANCREATIC CANCER GROWTH

Author

Tommaso Mello, Stefano Milani, F. Buccoliero, M. Farsi, S. Nesi, Andrea Galli, S. Tempesti, Elisabetta Ceni, Simone Polvani, M. D'Amico, V. Nieri, and Mirko Tarocchi

Subjects
Hepatology, Downregulation and upregulation, business.industry, Pancreatic cancer, Gastroenterology, Cancer research, medicine, medicine.disease, business, COUP-TFII
Published
2013
Full Text
View/download PDF

20. Transient elastography (TE) is more effective for the identification of HCV patients with severe (≥F3) rather than significant (≥F2) liver fibrosis

Author

Cristina Stasi, Fabio Marra, U. Arena, S. Moscarella, A. Petrarca, Juan G. Abraldes, Francesco Vizzutti, Stefano Milani, Giampaolo Corti, E. Lorefice, Massimo Pinzani, and Giacomo Laffi

Subjects
Pathology, medicine.medical_specialty, Hepatology, business.industry, Liver fibrosis, Gastroenterology, Medicine, Identification (biology), Transient elastography, business
Published
2008
Full Text
View/download PDF

21. Association of plasma homocysteine with bone mineral density in postmenopausal women with osteoporosis or osteopenia affected by primary biliary cirrhosis

Author

E. Bongini, Stefano Milani, Maria Rosa Biagini, M.C. Benini, Alessandro Tozzi, N. Lazzerini, M. Capanni, and Calogero Surrenti

Subjects
Bone mineral, medicine.medical_specialty, Postmenopausal women, Hepatology, business.industry, Osteoporosis, Gastroenterology, medicine.disease, Osteopenia, Primary biliary cirrhosis, Internal medicine, Plasma homocysteine, Medicine, business
Published
2006
Full Text
View/download PDF

23. Helicobacter pylori stool antigen test before and after eradication therapy

Author

Calogero Surrenti, M. Nuti, M. Ortolani, E. Surrenti, Stefano Milani, B. Ottanelli, and B. Orsini

Subjects
Adult, Male, medicine.medical_specialty, Helicobacter pylori, Hepatology, business.industry, Gastroenterology, Middle Aged, Antibodies, Bacterial, Helicobacter Infections, Feces, Internal medicine, medicine, Humans, Female, Helicobacter pylori stool antigen test, business, Aged
Published
2003
Full Text
View/download PDF

24. O4 BERBERINE ADMINISTRATION AMELIORATES EXPERIMENTAL STEATOHEPATITIS INTERFERING WITH THE INFLAMMASOME PATHWAY AND TLR-4 EXPRESSION

Author

E. Vivoli, Maurizio Parola, Fabio Marra, G. Moneti, A. Provenzano, C.P.M.S. Oliveira, Stefano Milani, S. Madiai, and Erica Novo

Subjects
chemistry.chemical_compound, Berberine, Hepatology, chemistry, business.industry, Gastroenterology, medicine, Inflammasome, Pharmacology, Steatohepatitis, business, medicine.disease, medicine.drug
Published
2012
Full Text
View/download PDF

27. T-32 In vivo and in vitro models support the therapeutic effects of acycloguanosyl 5’-thymidyltriphosphate for the hepatocellular carcinoma via telomerase activation

Author

M. Calamante, Tommaso Mello, Simone Polvani, Mirko Tarocchi, Stefano Milani, F. Buccoliero, C. Luchinat, Elisabetta Ceni, I. Bertini, and Andrea Galli

Subjects
Oncology, medicine.medical_specialty, Telomerase, Hepatology, business.industry, Therapeutic effect, Gastroenterology, medicine.disease, In vitro, In vivo, Internal medicine, Hepatocellular carcinoma, medicine, Cancer research, Acycloguanosyl 5'-thymidyltriphosphate, business
Published
2012
Full Text
View/download PDF

30. F-32 Dietary supplementation with olive oil with or without n-3 PUFA differentially affects inflammation and progression of experimental nonalcoholic steatohepatitis

Author

W. Delogu, A. Provenzano, N. Navari, Stefano Milani, Fabio Marra, Francesco Vizzutti, Erica Novo, Maurizio Parola, and Giacomo Laffi

Subjects
Nonalcoholic steatohepatitis, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Inflammation, Endocrinology, Internal medicine, medicine, Dietary supplementation, medicine.symptom, business, N 3 pufa, Olive oil
Published
2012
Full Text
View/download PDF

31. P.1.142: TELOMERASE ACTIVATED THYMIDINE ANALOGUE PRO-DRUG IS A NEW MOLECULE TARGETING HEPATOCELLULAR CARCINOMA

Author

Andrea Galli, Elisabetta Ceni, Mirko Tarocchi, F. Buccoliero, Simone Polvani, Stefano Milani, L. Cioni, and Tommaso Mello

Subjects
Oncology, medicine.medical_specialty, Telomerase, Hepatology, business.industry, Thymidine analogue, Gastroenterology, Prodrug, medicine.disease, Internal medicine, Hepatocellular carcinoma, medicine, Cancer research, Telomerase reverse transcriptase, business
Published
2011
Full Text
View/download PDF

33. P.1.278: METABOLOMIC ANALYSIS FOR NON INVASIVE DIAGNOSIS OF ADVANCED FIBROSIS AND EARLY CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS C

Author

M. Giannotta, Stefano Milani, Patrizia Bernini, E. Lorefice, Antonio Calabrò, T Gabbani, Maria Marsico, and Cecilia Grappone

Subjects
medicine.medical_specialty, Hepatology, Early cirrhosis, business.industry, Non invasive, Gastroenterology, Advanced fibrosis, Metabolomics, Chronic hepatitis, Internal medicine, medicine, In patient, business
Published
2011
Full Text
View/download PDF

34. F-49 A randomized multicentre double-blind vs placebo trial: Evaluation of effect of silybin conjugated with phosphatidilcholine and vitamin E on liver damage in patients with nonalcoholic fatty liver disease

Author

A. Smedile, Paolo Sorrentino, Carmela Loguercio, Concetta Tuccillo, Alessandro Federico, A. Grieco, M.C. Brisc, P. Andreone, S. Lobello, Piero Portincasa, Raffaella Vecchione, A. Floreani, Ioan Sporea, Lajos Okolicsanyi, Marco Chiaramonte, Stefano Milani, and M.A. Freni

Subjects
medicine.medical_specialty, Hepatology, business.industry, Vitamin E, medicine.medical_treatment, Gastroenterology, medicine.disease, Placebo, Double blind, Internal medicine, Nonalcoholic fatty liver disease, medicine, In patient, Liver damage, business
Published
2011
Full Text
View/download PDF

35. P.153 PES-003, A NEW PRO-DRUG FOR PANCREATIC CANCER THERAPY

Author

B. Ottanelli, Tommaso Mello, Stefano Milani, M. Calamante, L. Cioni, Elisabetta Ceni, G. Pieraccini, Andrea Galli, Mirko Tarocchi, G. Moneti, F. Buccoliero, Calogero Surrenti, C. Luchinat, V. Foresta, and Simone Polvani

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Pancreatic cancer, Internal medicine, Gastroenterology, medicine, Cancer, CA19-9, Prodrug, medicine.disease, business
Published
2010
Full Text
View/download PDF

36. P.131 VIRAL KINETICS IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH COMBINATION THERAPY WITH PEG-IFN AND NUCLEOSIDE ANALOGUES

Author

G. Elena, A. Farese, R. Puntili, Stefano Milani, F. Bucciero, Cristina Stasi, Al Zignego, Calogero Surrenti, S. Bresci, Giampaolo Corti, E. Lorefice, Paolo Forte, and Carlo Giannini

Subjects
Hepatology, Chronic hepatitis, Combination therapy, business.industry, Gastroenterology, Medicine, In patient, business, Nucleoside, Virology, Viral kinetics
Published
2010
Full Text
View/download PDF

37. T.N.23 ROSIGLITAZONE INHIBITS HEPATOCELLULAR CANCER CELL GROWTH AND DOWN-REGULATES RUVBL-1: EVIDENCES OF A PPARgamma-INDEPENDENT MECHANISM OF CELL GROWTH INHIBITION

Author

V. Foresta, Stefano Milani, F. Buccoliero, L. Cioni, Calogero Surrenti, Tommaso Mello, Simone Polvani, Mirko Tarocchi, Elisabetta Ceni, B. Ottanelli, and Andrea Galli

Subjects
Hepatocellular cancer, Hepatology, Cell growth, Mechanism (biology), business.industry, Gastroenterology, Cancer research, medicine, Growth factor receptor inhibitor, Rosiglitazone, business, medicine.drug
Published
2010
Full Text
View/download PDF

40. THIAZOLIDINEDIONES INHIBIT HEPATIC TUMOUR FORMATION IN HBV TRANSGENIC MICE BY A PPARγ-INDEPENDENT REGULATION OF NUCLEOPHOSMIN

Author

G. Moneti, B. Ottanelli, F. Buccoliero, Tommaso Mello, L. Cioni, Andrea Galli, Stefano Milani, Calogero Surrenti, V. Foresta, Simone Polvani, Mirko Tarocchi, Elisabetta Ceni, F. Lisi, G. Mastrobuoni, and Maria Rosa Biagini

Subjects
Genetically modified mouse, Nucleophosmin, Hepatology, business.industry, Gastroenterology, Cancer research, Medicine, Hepatic tumour, business
Published
2009
Full Text
View/download PDF

41. SILENCING OF ARP-1 NUCLEAR RECEPTOR REDUCES PANCREATIC CANCER GROWTH IN VITRO AND IN VIVO

Author

B. Ottanelli, V. Foresta, Calogero Surrenti, Simone Polvani, Elisabetta Ceni, Mirko Tarocchi, Andrea Galli, F. Martini, F. Lisi, F. Buccoliero, R. Moretti, L. Cioni, Stefano Milani, and Tommaso Mello

Subjects
Hepatology, Nuclear receptor, In vivo, business.industry, Pancreatic cancer, Gastroenterology, medicine, Cancer research, Gene silencing, medicine.disease, business, In vitro
Published
2009
Full Text
View/download PDF

42. PA.104 PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN

Author

Sara Renzo, Calogero Surrenti, M. Capanni, E. Gianni, E. Lorefice, Paolo Forte, M. Paci, and Stefano Milani

Subjects
medicine.medical_specialty, Hepatology, business.industry, Ribavirin, Gastroenterology, Virological response, chemistry.chemical_compound, Chronic hepatitis, chemistry, Pegylated interferon, Internal medicine, medicine, In patient, business, medicine.drug
Published
2008
Full Text
View/download PDF

43. Occurrence of tuberculous spondylitis after peg-interferon alfa-2b plus ribavirin combination therapy for chronic hepatitis C

Author

Stefano Milani, Alessandro Tozzi, Maria Rosa Biagini, Calogero Surrenti, Andrea Galli, M.C. Benini, M. Capanni, and E. Lorefice

Subjects
medicine.medical_specialty, Hepatology, Combination therapy, business.industry, Ribavirin, Gastroenterology, medicine.disease, chemistry.chemical_compound, chemistry, Chronic hepatitis, Internal medicine, medicine, PEG-interferon alfa-2b, business, Spondylitis
Published
2006
Full Text
View/download PDF

44. Comparison between combination therapy with peg-interferon alfa-2A plus ribavirin and peg-interferon alfa-2B plus ribavirin in the treatment of chronic hepatitis C

Author

E. Gai, Alessandro Tozzi, M. Capanni, Stefano Milani, Andrea Galli, Maria Rosa Biagini, S. Nanni, E. Lorefice, M.C. Benini, Calogero Surrenti, and M. Paci

Subjects
medicine.medical_specialty, Hepatology, Combination therapy, business.industry, Ribavirin, Gastroenterology, chemistry.chemical_compound, Chronic hepatitis, chemistry, Internal medicine, Medicine, PEG-interferon alfa-2a, PEG-interferon alfa-2b, business
Published
2006
Full Text
View/download PDF

45. Autoimmune hepatitis: Description of an Italian population

Author

Andrea Galli, N. Lazzerini, Calogero Surrenti, M. Capanni, Maria Rosa Biagini, Stefano Milani, C. Rastelli, and M.C. Benini

Subjects
Hepatology, business.industry, Immunology, Gastroenterology, Medicine, Autoimmune hepatitis, business, medicine.disease, Italian population
Published
2006
Full Text
View/download PDF

46. Detection of hepatocellular carcinoma during the treatment with pegylated interferon alfa-2a and ribavirin for chronic hepatitis C

Author

Alessandro Tozzi, Maria Rosa Biagini, Stefano Milani, Andrea Galli, M.C. Benini, E. Lorefice, Calogero Surrenti, and M. Capanni

Subjects
medicine.medical_specialty, Hepatology, business.industry, Ribavirin, Gastroenterology, medicine.disease, chemistry.chemical_compound, Pegylated interferon alfa-2a, Chronic hepatitis, chemistry, Internal medicine, Hepatocellular carcinoma, Medicine, business
Published
2006
Full Text
View/download PDF

47. Acetaldehyde induced collagen synthesis by inhibition of ppargamma transcriptional activity via hydrogen peroxide-mediated activaction of C-ABL non-receptor tyrosine kinase in human hepatic stellate cells

Author

Elisabetta Ceni, Stefano Milani, Andrea Galli, Calogero Surrenti, F. Lisi, Mirko Tarocchi, Tommaso Mello, L. Cioni, Marco Foschi, and F. Buccoliero

Subjects
Non-receptor tyrosine kinase, ABL, Hepatology, biology, business.industry, Gastroenterology, Acetaldehyde, Tropomyosin receptor kinase C, Receptor tyrosine kinase, Cell biology, chemistry.chemical_compound, chemistry, Biochemistry, biology.protein, Hepatic stellate cell, Medicine, Hydrogen peroxide, business, Platelet-derived growth factor receptor
Published
2006
Full Text
View/download PDF

48. 7 P High prevalence of hypercoagulability state and elevated plasma levels of homocysteine in patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)

Author

Maria Rosa Biagini, Stefano Milani, C. Surreni, Andrea Galli, Raffaele Manta, R. Marcucci, Rosanna Abbate, E. Anronucci, Sandra Fedi, and R. Paniccia

Subjects
medicine.medical_specialty, High prevalence, Hepatology, Homocysteine, business.industry, Gastroenterology, Plasma levels, medicine.disease, Primary sclerosing cholangitis, chemistry.chemical_compound, Primary biliary cirrhosis, chemistry, Hypercoagulability State, Internal medicine, medicine, In patient, business
Published
2002
Full Text
View/download PDF

49. 4 PS Antidiabetic thiazolidinediones inhibit growth and invasiveness of pancreatic cancer cells via a ppargamma dependent and independent manner

Author

Tommaso Mello, Cecilia Grappone, E. Surrenti, Stefano Milani, Andrea Galli, Alessandro Casini, Elisabetta Ceni, Calogero Surrenti, Raffaele Manta, R. Salzano, and David W. Crabb

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Pancreatic cancer, Gastroenterology, medicine, Cancer research, medicine.disease, business
Published
2002
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results